Home › OncoSec Medical Incorporated: The Best Immuno-Oncology Biotech You've Never Heard Of
 

Keywords :   


OncoSec Medical Incorporated: The Best Immuno-Oncology Biotech You've Never Heard Of

2015-06-25 06:21:30| Biotech - Topix.net

Newly uplisted, small cap biotech OncoSec is making big advancements in the immuno-oncology space with its unique ImmunoPulse intratumor delivery technology. OncoSec has a market cap of only ~$100M, over $30M in cash, several Phase 2 clinical trials underway, impressive clinical data and the potential to revolutionize immuno-oncology treatment.

Tags: of medical heard incorporated

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
15.05Indian spices face heat over global safety concerns
15.05'Corrupt ship inspectors demand our food and cargo'
15.05Taylor Swift Eras Tour to boost UK spending by 1bn, says report
15.05Three ways to win the rental property race
15.05Renters in scrum for homes as listing time slashed
14.05Nu Skin Releases 2023 Social Impact and Sustainability Report
14.05P&G Unveils Plans to Feature Brands During the Olympic and Paralympic Games Paris 2024
14.05The LOccitane Group Appoints Evelyne LY-Wainer Managing Director Global Travel Retail
More »